Research & Reviews: A Journal of Pharmacology

ISSN: 2230-9861

Editors Overview

rrjop maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Open Access
Special Issue

Novel inhalation formulations of optimyxin

Abstract Submission Deadline : November 30, 2023

Manuscript Submission Deadline : December 25, 2023

Special Issue Description

Due to bacterial resistance and limited drug exposure at the infection site, intravenous and oral antibiotics are not usually effective for treating lung infections. A novel optimyxin combo medication has been created by Purdue University researchers to treat bacterial lung infections. Infections brought on by multi-drug resistant Gram-negative “superbugs” have frequently been treated with optimyxin as a last resort; nevertheless, inhaled optimyxin can be harmful to the lungs. In comparison to the commonly used breathed optimyxin B and colistin, the novel formulations created by Purdue researchers create a potent therapeutic option with superior antibacterial killing and much-reduced toxicity. The Purdue dry powder formulation, which exhibits good stability and strong aerosolization capability, also shows potential as an inhaled treatment.


*Dry powder inhaler
*Klebsiella pneumonia
*Enhanced efficacy

Manuscript Submission information

Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.

Participating journals: